Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: A randomized study

Gynecological Endocrinology

Volumn 24, Issue 8, 2008, Pages 475-480

  Hallberg, Gunilla ^a,d   Persson, Ingemar ^b,c   Naessén, Tord ^a   Magnusson, Cecilia ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estrogen receptor ; Human breast tissue; Oral contraceptives; Postmenopausal; Premenopausal; Progesterone receptor

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN RECEPTOR ALPHA; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLLITROPIN; HORMONE RECEPTOR; LEVONORGESTREL; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST; BREAST REDUCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE SEQUENCE; ESTROGEN THERAPY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; NULLIPARA; ORAL CONTRACEPTION; PARITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TISSUE SECTION;

ADULT; AGED; ALGORITHMS; CONTRACEPTIVES, ORAL, HORMONAL; DRUG THERAPY, COMBINATION; ESTROGEN RECEPTOR ALPHA; FEMALE; FOLLICULAR PHASE; GONADAL STEROID HORMONES; HUMANS; LUTEAL PHASE; MAMMARY GLANDS, HUMAN; MIDDLE AGED; PARITY; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 53849122645     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802234204     Document Type: Article

References (29)

1. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998;90:814-823.
2. Anderson E, Clarke RB. Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia 2004;9:3-13.
3. Collaborative Group in Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-1727.
4. Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M. Hormone replacement therapy and breast cancer in former users of oral contraceptives. The Norwegian Women and Cancer study. Int J Cancer 2007;121:645-648.
5. Magnusson C, Persson RI, Baron AJ, Correia N, Bergström R, Adami H-O. Breast cancer risk following long-term oestrogen and oestrogen-progestogen replacement therapy. Int J Cancer 1999;81:339-344.
6. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
7. Conover WJ. Practical non parametric statistics. New York: John Wiley & Sons; 1999.
8. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
9. Battersby S, Robertson BJ, Anderson TJ, King RJB, McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992;65:601-607.
10. Eigeliene N, Härkönen P, Erkkola R. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer 2006;6:246.
11. Isaksson E, Sahlin L, Söderqvist G, von Schoultz E, Masironi B, Wickman M, Wilking N, von Schoultz B, Skoog L. Expression of sex steroid receptors and IGF-1 mRNA in breast tissue - effects of hormonal treatment. J Steroid Biochem Mol Biol 1999;70:257-262.
12. Markopoulos C, Berger U, Wilson P, Gazet J-C, Coombes RC. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. BMJ 1988;296:1349-1351.
13. Cheng G, Li Y, Omoto Y, Wang Y, Berg T, Nord M, Vikho P, Warner M, Piao YS, Gustafsson JA. Differential regulation of estrogen receptor (ER) α and ERβ in primate mammary gland. J Clin Endocrinol Metab 2005;90:435-444.
14. Khan SA, Rogers MAM, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998;90:37-42.
15. Söderqvist G, von Schoultz B, Tani E, Skoog L. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. Am J Obstet Gynecol 1993;168:874-887.
16. Cline JM, Söderqvist G, von Schoultz B, Skoog L, von Schoultz E. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal macaques. Am J Obstet Gynecol 1996;174:93-100.
17. Hofseth LJ, Raafat AM, Ouch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999;84:4559-4565.
18. Hargreaves DF, Knox F, Swindell R, Potten CS, Bundred NJ. Epithelial proliferation and hormone receptor status in the normal postmenopausal breast and the effects of hormone replacement therapy. Br J Cancer 1998;78:945-949.
19. Isaksson E, von Schoultz E, Odlind V, Söderqvist G, Csemiczky G, Carlström K, Skoog L, von Schoultz B. Effects of oral contraceptives on breast proliferation. Breast Cancer Res Treat 2001;65:163-169.
20. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D. Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999;354:1787-1788.
21. Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MP, Sibson DR, Sloane JP. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 1999;155:1811-1815.
22. Zeps N, Bentel JM, Papadimitriou JM, D'Antuono MF, Dawkins HJ. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 1998;62:221-226.
23. Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997;57:4987-4991.
24. Clarke RB, Howell A, Anderson E. Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 1997;45:121-133.
25. Söderqvist G, Isaksson E, von Schoultz B, Carlström K, Tani E, Skoog L. Proliferation on breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997;176:123-128.
26. Clarke RB. Human breast cell proliferation and its relationship to steroid receptor expression. Climacteric 2004;7:129-137.
27. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996;76:69-125.
28. Smith RA, Lea RA, Weinstein SR, Griffiths LR. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma. Cancer Lett 2007;255:77-84.
29. Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO. The effect of progesterone, testosterone and synthetic progestogens on growth factor and estradiol treated human cancerous and benign breast cells. Eur J Obstet Gynecol Reprod Biol 2006;129:77-83.